Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ChemoCentryx, Inc. - Common Stock (NQ: CCXI )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 19, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about ChemoCentryx, Inc. - Common Stock

< Previous 1 2 3 Next >
ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings
From ChemoCentryx, Inc.
Via GlobeNewswire
ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
From ChemoCentryx, Inc.
Via GlobeNewswire
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI
From Scott+Scott Attorneys at Law LLP
Via Business Wire
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI
From Scott+Scott Attorneys at Law LLP
Via Business Wire
ChemoCentryx (NASDAQ: CCXI) to be Acquired by Amgen (NASDAQ: AMGN) for $3.7 Billion in Cash
ChemoCentryx, Inc. (NASDAQ: CCXI) is engaged as a biopharmaceutical company that is focused on the research, development and commercialization of 
Via Spotlight Growth
CCXI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of ChemoCentryx, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
NASDAQ: CCXI Investor Notice: Update in Lawsuit Against ChemoCentryx, Inc. Announced
San Diego, CA -- (SBWIRE) -- 04/26/2022 -- An update was announced in the lawsuit that is pending for certain investors in in shares of ChemoCentryx, Inc. (NASDAQ: CCXI) against ChemoCentryx, Inc.over... 
Via SBWire
CHEMOCENTRYX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ChemoCentryx, Inc. - CCXI
From Kahn Swick & Foti, LLC
Via Business Wire
NASDAQ:CCXI Long Term Investor Alert: Investigation of Potential Wrongdoing at ChemoCentryx, Inc.
San Diego, CA -- (SBWIRE) -- 02/24/2022 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of ChemoCentryx, Inc. 
Via SBWire
NASDAQ:CCXI Investor Notice: Investigation over Possible Securities Laws Violations by ChemoCentryx, Inc.
San Diego, CA -- (SBWIRE) -- 02/22/2022 -- ChemoCentryx, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
SHAREHOLDER ALERT: Robbins LLP Investigates ChemoCentryx, Inc. (CCXI) on Behalf of Shareholders
From Robbins LLP
Via Business Wire
NASDAQ:CCXI Long Term Shareholder Notice: Investigation over Potential Wrongdoing at ChemoCentryx, Inc.
San Diego, CA -- (SBWIRE) -- 09/15/2021 -- Certain directors of ChemoCentryx, Inc. are under investigation concerning potential breaches of fiduciary duties. 
Via SBWire
Topics Lawsuit
Exposures Financial Legal
CCXI DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of ChemoCentryx, Inc. of Deadline in Securities Fraud Class Action Lawsuit
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
CHEMOCENTRYX 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against ChemoCentryx, Inc. - CCXI
From Kahn Swick & Foti, LLC
Via Business Wire
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against ChemoCentryx, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
CCXI CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ChemoCentryx, Inc.
NEW YORK, NY / ACCESSWIRE / June 30, 2021 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class... 
From Bernstein Liebhard LLP
Via AccessWire
Topics Lawsuit
Exposures Financial Legal Product Safety
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
From The Law Offices of Frank R. Cruz
Via Business Wire
CCXI Approaching Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds ChemoCentryx, Inc. Investors of Class Action and Lead Plaintiff Deadline: July 6, 2021
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
TUESDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
7-DAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
NASDAQ:CCXI Investor Notice: Deadline on July 6, 2021 in Lawsuit Against ChemoCentryx, Inc.
San Diego, CA -- (SBWIRE) -- 06/28/2021 -- A deadline is coming up on July 6, 2021 in the lawsuit filed for certain investors of ChemoCentryx, Inc. (NASDAQ:CCXI). 
Via SBWire
Topics Lawsuit
Exposures Financial Legal
UPCOMING DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
UPCOMING DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
UPCOMING DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
UPCOMING DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, NATIONAL TRIAL LAWYERS, Encourages ChemoCentryx, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important July 6 Deadline in Securities Class Action – CCXI
From Rosen Law Firm
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.